842 related articles for article (PubMed ID: 15199458)
1. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
[TBL] [Abstract][Full Text] [Related]
3. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
Rosborough TK; Jacobsen JM; Shepherd MF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
[TBL] [Abstract][Full Text] [Related]
4. Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
Casimire T; Carter R; Peters S; Tweedle J; Charles KS
Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306
[TBL] [Abstract][Full Text] [Related]
5. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
Oertel LB
Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
Edwards HD; Webb RD; Conway SE
Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
Tripodi A; Breukink-Engbers WG; van den Besselaar AM
Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
[TBL] [Abstract][Full Text] [Related]
8. An algorithm for managing warfarin resistance.
Osinbowale O; Al Malki M; Schade A; Bartholomew JR
Cleve Clin J Med; 2009 Dec; 76(12):724-30. PubMed ID: 19952297
[TBL] [Abstract][Full Text] [Related]
9. "Zeus" a new oral anticoagulant therapy dosing algorithm: a cohort study.
Cafolla A; Melizzi R; Baldacci E; Pignoloni P; Dragoni F; Campanelli M; Caraccini R; Foà R
Thromb Res; 2011 Oct; 128(4):325-30. PubMed ID: 21600633
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
Meijer K; Kim YK; Carter D; Schulman S
Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
[TBL] [Abstract][Full Text] [Related]
11. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
12. Home prothrombin time monitoring: a literature analysis.
Yang DT; Robetorye RS; Rodgers GM
Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909
[TBL] [Abstract][Full Text] [Related]
13. Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies.
Siegmund HU; Burghaus R; Kubitza D; Coboeken K
Br J Clin Pharmacol; 2015 Jun; 79(6):959-66. PubMed ID: 25510952
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
[TBL] [Abstract][Full Text] [Related]
15. Warfarin therapy: evolving strategies in anticoagulation.
Horton JD; Bushwick BM
Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
[TBL] [Abstract][Full Text] [Related]
16. Management of oral anticoagulant treatment in patients with venous thromboembolism.
Pengo V
Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.
Yamreudeewong W; Johnson JV; Cassidy TG; Berg JT
Pharmacotherapy; 1996; 16(6):1159-65. PubMed ID: 8947990
[TBL] [Abstract][Full Text] [Related]
18. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
[TBL] [Abstract][Full Text] [Related]
19. Long-term standard-dose warfarin to prevent thrombosis.
Depenbrock PJ
Am Fam Physician; 2005 Jul; 72(1):36, 41. PubMed ID: 16035681
[No Abstract] [Full Text] [Related]
20. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
